Give the outcome a job
What change matters to you: less tiredness, fewer symptoms, better attention? Keep that question beside the paper. It gives you something firmer to check than whether the result sounds encouraging.
NMN is nicotinamide mononucleotide, a building block for NAD+. NAD+ helps cells handle energy. A trial tested NMN in women past menopause who had prediabetes, a blood-sugar condition. Their muscle responded better to insulin, the hormone that helps manage blood sugar.
Neither body composition nor a measure of blood sugar over time changed in that trial. That leaves a specific muscle finding, not an answer about feeling more energetic. Both halves of the result matter.
Keep the kind of link visible
A mechanism is a possible explanation of how something works. An association is a pattern: two things occur together. A treatment test compares what happens when people receive something with what happens in a comparison group.
Take KPV, a tiny peptide studied for inflammation. Its gut-cell and mouse research helps explain why researchers got interested. FDA’s review found no human evidence of benefit. The interesting lead and the missing answer can both be true.
When a study does involve people, I check who took part and for how long. “Studied in humans” isn’t a free pass. The people, the comparison and the outcome still need to fit the question.
A brain signal still leaves a memory question
The Semax brain-scan study in healthy volunteers found a difference in resting activity. It didn’t establish that people remembered appointments better or found daily tasks easier.
That’s the next question I’d take to the source: did anyone measure the performance I care about? A scan tells you what the scan found. The extra everyday claim needs extra evidence.

Leave room for a result that disappoints
I give unchanged outcomes the same attention as improved ones. Otherwise a study can turn into a much rosier story simply by losing a sentence.
For DSIP, a peptide studied for sleep, an older insomnia trial reported modest effects. The authors also questioned the likely practical benefit of short-term treatment alone. Dropping that caution changes the answer.
A small study may be a reason to do another study. It needn’t settle your decision. If a paper leaves your question open, finding that out is useful work too.